Rhinovirus and Airway Epithelial Cell Responses
Rhinovirus and Airway Epithelial Cell Responses
批准号:
7386619
负责人:
Marc B. Hershenson
金额:
$36.9万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-15 至 2011-03-31
关键词:
1-Phosphatidylinositol 3-KinaseAccident and Emergency departmentAccountingAcuteAdultAirAllergicAsthmaBiochemicalBronchial LavagesCXC ChemokinesCellsChildClassCommon ColdDataDiseaseEnhancersEpithelialEpithelial CellsEventExtracellular Signal Regulated KinasesFamily PicornaviridaeGrowthHumanICAM1 geneInfectionInflammationInflammatoryInflammatory ResponseIntercellular adhesion molecule 1Interleukin-13Interleukin-8LeadLife Cycle StagesLigationLiquid substanceMediatingMembrane MicrodomainsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesMusNADPH OxidaseNoseOncogenesPathway interactionsPatientsPhosphoinositide-3-Kinase, Catalytic, Gamma PolypeptidePhosphorylationPhosphotransferasesPilot ProjectsProductionRNA VirusesResearch PersonnelRhinovirusSignal PathwaySignal TransductionSiteTestingTransactivationTranscription Factor AP-1Tumor Necrosis Factor-alphaTumor Necrosis FactorsViralVirus Diseasesairway inflammationbasechemokinechemokine receptorcytokinehuman TNF proteinin vivoleucylargininemacrophage inflammatory protein 2neutrophilp65programspromoterresponsesize
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rhinovirus (RV) infection accounts for a large fraction of asthma exacerbations. Airway neutrophils and IL-8
levels are increased in RV-induced exacerbations, suggesting that RV stimulates exacerbations by inducing
epithelial cell expression of (El_R)+ C-X-C chemokines, leading to an exaggerated inflammatory response.
In pilot studies, we have shown that RV39 induces IL-8, ENA-78 and GRO-ct expression in primary, mu-
cociliary-differentiated human tracheal epithelial cells. In 16HBE14o- cells, RV39 infection activates Src, PI
3-kinase, Akt and ERK minutes after infection, and activation of these kinases is required for IL-8 expression.
RV increases C-X-C chemokine expression induced by two pro-asthmatic cytokines, IL-13 and TNFa. Fi-
nally, RV1B infection of C57/BL6 mice increases airway neutrophils and levels of MIP-2, a murine ELR(+) C-
X-C chemokine. Wetherefore hypothesize that RV is sufficient to activate biochemical signalingpathways
involved in the asthmatic response, providing a mechanism for RV-induced asthma exacerbations.
Specific Aim 1: Characterize upstream activators and downstream effectors of PI 3-kinase required for
RV-induced ELR(+) C-X-C chemokine expression. We hypothesize that: 1) RV colocalizes with Src, PI 3-
kinase, Akt and Grb2 in lipid rafts; 2) Src is required for activation of the PI 3-kinase/Akt pathway; 3) Class
IA, II and III PI 3-kinases are required for maximal RV-induced expression of IL-8, ENA-78 and GROot; and
4) maximal NF-KB activation requires PI 3-kinase-dependent activation of NADPH oxidase.
Specific Aim 2: Determine the biochemical signaling mechanisms responsible for cooperative effects of
RV and pro-asthmatic cytokines on airway epithelial cell IL-8 expression. We hypothesize that: 1) ERKand
JNK regulate IL-8 expression via activation of the AP-1 promoter site, which functions as a basal level en-
hancer; 2) additive effects of RV39 and TNFa are mediated by increased p65 RelA phosphorylation and NF-
transactivation; 3) synergistic effects of RV39 and IL-13 are mediated by increased AP-1 transactivation.
Specific Aim 3: Determine the steps in the viral life cycle required or sufficient for RV-induced signaling
and chemokine responses and, conversely, determine the requirement of host cell signal transduction for
viralinfection. We hypothesize that: 1) ICAM1 ligation is required and sufficient for activation of Src, PI 3-
kinase, Akt, ERK and JNK; 2) viral replication is not required for activation of these signaling intermediates;
and 3) PI 3-kinase activation is required for RV39 internalization.
Specific Aim 4: Determine the requirements of PI 3-kinase signaling and ELR(+) C-X-C chemokines for
RV-inducedresponses in vivo. We hypothesize that: 1) RV1B infection is sufficient for airway inflammation
and epithelial cell signaling in vivo; 2) PI 3-kinase is required for RV1B-induced airway inflammation in vivo;
and 3) C-X-C chemokine receptor (CXCR)-2 regulates RV1B-induced airway inflammation in vivo.
Understandina RV-induced asthma exacerbations will lead to improvements in the treatment of this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10093541
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10682418
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10459511
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10268220
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Respiratory Enteroviruses, Inflammasome Activation and Innate Immune Cells
-
批准号:10299951
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:9128143
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2016
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:9233004
-
项目类别:
-
资助金额:$44.67万
-
财政年份:2016
-
负责人:Marc B. Hershenson
-
依托单位:
S-Nitrosothiol-Based Rinse/Aerosol Solutions For Treatment/Prevention of Rhinosinusitis
-
批准号:8980847
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10443694
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10651800
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10200651
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Rhinovirus and Airway Epithelial Cell Responses
-
批准号:7822366
-
项目类别:
-
资助金额:$2.4万
-
财政年份:2009
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7642308
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7497962
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7666430
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7877980
-
项目类别:
-
资助金额:$40.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7334302
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7881828
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Mechanisms of Airway Smooth Muscle Hypertrophy
-
批准号:7266235
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位:
Rhinovirus and Airway Epithelial Cell Responses
-
批准号:8039582
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位: